echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Yangtze River Health: The State Food and Drug Administration agrees to change the holder of the marketing license for caspofungin acetate for injection

    Yangtze River Health: The State Food and Drug Administration agrees to change the holder of the marketing license for caspofungin acetate for injection

    • Last Update: 2021-03-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On March 18, the Yangtze River Health announced that the State Food and Drug Administration agreed that caspofungin acetate for injection (drug approval number: Sinopharm Zhunzi H202003001, Sinopharm Zhunzi H202003002, specifications 50mg, 70mg) drug marketing license holders "Borui Pharmaceutical (Suzhou) Co.


    Caspofungin, a semi-synthetic lipopeptide of the echinocandin family, is an antifungal drug with a new mechanism of action, which can inhibit a basic component of the cell wall of many filamentous fungi and yeasts—β (1,3 )-D-glucan is synthesized to play a bactericidal effect, has good curative effect and tolerability, and has little toxicity.


    Caspofungin acetate for injection is a national medical insurance category B and a national essential drug.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.